- Home
- GMED vs AS Comparison
GMED vs AS Comparison
Compare GMED & AS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- AS
- Stock Information
- Founded
- GMED 2003
- AS 1950
- Country
- GMED United States
- AS Finland
- Employees
- GMED N/A
- AS N/A
- Industry
- GMED Medical/Dental Instruments
- AS
- Sector
- GMED Health Care
- AS
- Exchange
- GMED Nasdaq
- AS NYSE
- Market Cap
- GMED 11.2B
- AS 9.5B
- IPO Year
- GMED 2012
- AS 2024
- Fundamental
- Price
- GMED $81.11
- AS $19.31
- Analyst Decision
- GMED Buy
- AS Buy
- Analyst Count
- GMED 14
- AS 14
- Target Price
- GMED $86.15
- AS $19.57
- AVG Volume (30 Days)
- GMED 1.0M
- AS 1.8M
- Earning Date
- GMED 11-05-2024
- AS 11-19-2024
- Dividend Yield
- GMED N/A
- AS N/A
- EPS Growth
- GMED N/A
- AS N/A
- EPS
- GMED 0.67
- AS N/A
- Revenue
- GMED $2,478,596,000.00
- AS $4,638,000,000.00
- Revenue This Year
- GMED $62.26
- AS $19.93
- Revenue Next Year
- GMED $6.76
- AS $13.21
- P/E Ratio
- GMED $120.85
- AS N/A
- Revenue Growth
- GMED 102.10
- AS 17.32
- 52 Week Low
- GMED $44.02
- AS $10.11
- 52 Week High
- GMED $84.87
- AS $20.68
- Technical
- Relative Strength Index (RSI)
- GMED 64.46
- AS 56.37
- Support Level
- GMED $79.94
- AS $17.84
- Resistance Level
- GMED $83.74
- AS $20.68
- Average True Range (ATR)
- GMED 1.85
- AS 0.81
- MACD
- GMED 0.38
- AS 0.02
- Stochastic Oscillator
- GMED 67.47
- AS 57.78
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
About AS AMER SPORTS INC
Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $4.4 billion in 2023. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2023, the firm generates 40% of its revenue from the Americas, 33% from Europe, the Middle East, and Africa, 19% from China, and 7% from Asia-Pacific, excluding China.